MedPath

BAFNA PHARMACEUTICALS PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

TGA:7

Drug Approvals

OXAZEPAM MYLAN oxazepam 15mg tablet bottle (369610)

Product Name
OXAZEPAM MYLAN oxazepam 15mg tablet bottle
Approval Date
Oct 11, 2021
TGA

OXAZEPAM MYLAN oxazepam 30mg tablet bottle (369611)

Product Name
OXAZEPAM MYLAN oxazepam 30mg tablet bottle
Approval Date
Oct 11, 2021
TGA

ACRIS Once-a-Month risedronate sodium (as hemipentahydrate) 150 mg film-coated tablet blister pack (196060)

Product Name
ACRIS Once-a-Month risedronate sodium (as hemipentahydrate) 150 mg film-coated tablet blister pack
Approval Date
Feb 4, 2013
TGA

RABEPRAZOLE ALPHAPHARM rabeprazole sodium 20 mg enteric-coated tablet blister pack (187312)

Product Name
RABEPRAZOLE ALPHAPHARM rabeprazole sodium 20 mg enteric-coated tablet blister pack
Approval Date
Aug 22, 2012
TGA

RABEPRAZOLE ALPHAPHARM rabeprazole sodium 10 mg enteric-coated tablet blister pack (187314)

Product Name
RABEPRAZOLE ALPHAPHARM rabeprazole sodium 10 mg enteric-coated tablet blister pack
Approval Date
Aug 22, 2012
TGA

ACRIS risedronate sodium 35 mg film-coated tablet blister pack (163785)

Product Name
ACRIS risedronate sodium 35 mg film-coated tablet blister pack
Approval Date
Nov 4, 2010
TGA

SORBIDIN isosorbide dinitrate 10mg tablet bottle (46043)

Product Name
SORBIDIN isosorbide dinitrate 10mg tablet bottle
Approval Date
Aug 10, 1993
TGA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.